Your browser doesn't support javascript.
loading
Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease.
Jiménez-Panizo, Alba; Pérez, Paloma; Rojas, Ana M; Fuentes-Prior, Pablo; Estébanez-Perpiñá, Eva.
Affiliation
  • Jiménez-Panizo A; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
  • Pérez P; Instituto de Biomedicina de Valencia (IBV)-CSIC, Valencia, Spain.
  • Rojas AM; Computational Biology and Bioinformatics Group, Andalusian Center for Developmental Biology (CABD-CSIC), Sevilla, Spain.
  • Fuentes-Prior P; Molecular Bases of Disease, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Estébanez-Perpiñá E; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
Endocr Relat Cancer ; 26(8): R479-R497, 2019 08.
Article de En | MEDLINE | ID: mdl-31252411
ABSTRACT
Nuclear receptors are transcription factors that play critical roles in development, homeostasis and metabolism in all multicellular organisms. An important family of nuclear receptors comprises those members that respond to steroid hormones, and which is subdivided in turn into estrogen receptor (ER) isoforms α and ß (NR3A1 and A2, respectively), and a second subfamily of so-called oxosteroid receptors. The latter includes the androgen receptor (AR/NR3C4), the glucocorticoid receptor (GR/NR3C1), the mineralocorticoid receptor (MR/NR3C2) and the progesterone receptor (PR/NR3C3). Here we review recent advances in our understanding of the structure-and-function relationship of steroid nuclear receptors and discuss their implications for the etiology of human diseases. We focus in particular on the role played by AR dysregulation in both prostate cancer (PCa) and androgen insensitivity syndromes (AIS), but also discuss conditions linked to mutations of the GR gene as well as those in a non-steroidal receptor, the thyroid hormone receptor (TR). Finally, we explore how these recent results might be exploited for the development of novel and selective therapeutic strategies.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Syndrome d'insensibilité aux androgènes / Récepteurs aux androgènes / Récepteurs cytoplasmiques et nucléaires Type d'étude: Etiology_studies Limites: Humans / Male Langue: En Journal: Endocr Relat Cancer Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Syndrome d'insensibilité aux androgènes / Récepteurs aux androgènes / Récepteurs cytoplasmiques et nucléaires Type d'étude: Etiology_studies Limites: Humans / Male Langue: En Journal: Endocr Relat Cancer Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: Espagne